hellocare.ai

Hellocare. ai is a US-based company specializing in integrated telehealth solutions that enhance healthcare delivery through advanced software, hardware, and artificial intelligence technologies. Founded in 2012 in Clearwater, US, Hellocare. ai provides a telehealth platform aimed at improving healthcare workflows.

The founders, Labinot Bytyqi, Mimoza Bytyqi, and Egzon Zeneli, established the company to address significant gaps in virtual care. In April 2025, the company raised USD 47 mn in growth funding, led by HealthQuest Capital with participation from Bon Secours Mercy Health and others, bringing its total amount raised to USD 47 mn. Hellocare. ai offers an integrated telehealth and virtual healthcare delivery platform that combines software, hardware, and artificial intelligence (AI) to enhance healthcare efficiency.

The core products include the AI-Assisted Virtual Nursing platform, which facilitates virtual rounding, admissions, and discharges, thereby improving patient care in hospitals. The company also provides a comprehensive Remote Patient Monitoring (RPM) system that captures and transmits vital health data from patients' medical devices to caregivers. Additional offerings include the Remote Examination Kit, enabling physicians to conduct remote examinations, and Telemedicine Carts that support mobile healthcare delivery. Hellocare products are designed for various sectors including hospitals, home care, and primary care, catering to a diverse client base of healthcare providers and clinicians across North America, Europe, and select markets in Asia.

Hellocare generates revenue primarily through a subscription-based model for its suite of telehealth solutions, including the AI-Assisted Virtual Nursing platform and Remote Patient Monitoring services. Clients, typically healthcare institutions and providers, enter into contractual agreements that provide access to the company's technology and ongoing support. Revenue is derived from these subscriptions, as well as potential revenue from the sale or lease of hardware components, such as Telemedicine Carts and the Remote Examination Kit. Pricing structures are designed to accommodate a range of healthcare settings, delivering scalable solutions that align with the operational needs of hospitals and home care providers.

The company’s focus on integrating advanced AI to enhance patient observation and care management further positions its products as essential tools within modern healthcare ecosystems. With the USD 47 mn raised in April 2025, Hellocare. ai plans to advance its growth and expansion efforts. The funding will support the development of new products and enhancements to existing platforms.

The company aims to enter additional markets, with specific focus on Europe and Asia by late 2025, further broadening its global footprint. The strategic use of these funds will facilitate the launch of innovative telehealth solutions to meet the increasing demand for virtual healthcare services.